Consolidated statements of comprehensive income

 View as excel [XLS - 38KB]


  Note   Audited

year
ended
30 June
2015
R'000
  Reviewed
twelve-month
period
ended
30 June
2014
R'000
  Audited
nine-month
period
ended
30 June
2014
R'000
 
REVENUE 2   5 558 926   5 234 739   3 640 780  
TURNOVER 2   5 528 369   5 193 070   3 615 287  
Cost of sales     (3 446 714)   (3 453 594)   (2 475 723)  
Gross profit     2 081 655   1 739 476   1 139 564  
Selling, distribution and marketing expenses     (1 115 231)   (998 169)   (727 671)  
Drug management and regulatory expenses     ( 119 288)   (110 719)   (81 096)  
Fixed and administrative expenses     (396 153)   (424 376)   (337 887)  
Trading profit/(loss)     450 983   206 212   (7 090)  
Non-trading expenses 3   (106 325)   (1 004 426)   (967 645)  
Operating profit/(loss)     344 658   (798 214)   (974 735)  
Finance income 2   19 887   30 344   18 987  
Finance costs     (100 983)   (131 461)   (98 620)  
Dividend income 2   10 670   11 325   6 506  
Equity-accounted earnings     65 608   52 061   31 895  
Profit/(Loss) before taxation     339 840   (835 945)   (1 015 967)  
Taxation     (141 031)   7 176   53 811  
Profit/(Loss) for the year/period     198 809   (828 769)   (962 156)  
Other comprehensive income which will subsequently be recycled to profit or loss     61 722   (46 806)   51 792  
   Exchange differences on translation of foreign operations     61 242   (34 372)   52 967  
   Fair value gain on available-for-sale asset, net of tax     403   677   350  
   Movement in cash flow hedge accounting reserve, net of tax     77   (13 111)   (1 525)  
Other comprehensive income which will not be recycled to profit or loss                
Actuarial loss on post-retirement medical liability     (442)   (6 880)   (6 880)  
Total comprehensive income for the year/period, net of tax     260 089   (882 455)   (917 244)  
Profit/(Loss) attributable to:                
Owners of the parent     197 932   (832 533)   (965 343)  
Non-controlling interests     877   3 764   3 187  
      198 809   (828 769)   (962 156)  
Total comprehensive income attributable to:                
Owners of the parent     260 419   (878 707)   (914 826)  
Non-controlling interests     (330)   (3 748)   (2 418)  
      260 089   (882 455)   (917 244)  
Basic earnings/(loss) per ordinary share (cents)     117.2   (493.7)   (572.3)  
Diluted basic earnings/(loss) per ordinary share (cents)     117.2   (493.4)   (571.9)  
Headline earnings/(loss) per ordinary share (cents)     160.1   (100.8)   (179.5)  
Diluted headline earnings/(loss) per ordinary share (cents)     160.1   (100.8)   (179.3)